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Abstract
Background: Cytotoxic T-Lymphocyte (CTL) response drives the evolution of HIV-1 at a host-level by selecting HLA-
restricted escape mutations. Dissecting the dynamics of these escape mutations at a population-level would help to
understand how HLA-mediated selection drives the evolution of HIV-1.
Methodology/PrincipalFindings:Weundertook astudyofthe dynamicsofHIV-1CTL-escapemutationsbyanalyzingthrough
statistical approaches and phylogenetic methods the viral gene gag sequenced in plasma samples collected between the
years 1987 and 2006 from 302 drug-naı ¨ve HIV-positive patients. By applying logistic regression models and after performing
correction for multiple test, we identified 22 potential CTL-escape mutations (p-value,0.05; q-value,0.2); 10 of these
associations were confirmed in samples biologically independent by a Bayesian Markov Chain Monte-Carlo method. Analyzing
their prevalence back in time we found that escape mutations that are the consensus residue in samples collected after 2003
have actually significantly increased in time in one of either B or F subtype until becoming the most frequent residue, while
dominating theotherviralsubtype. Theirestimatedprevalence intheviralsubtype they didnotdominatewaslowerthan30%
for the majority of samples collected at the end of the 80’s. In addition, when screening the entire viral region, we found that
the 75% of positions significantly changing in time (p,0.05) were located within known CTL epitopes.
Conclusions: Across HIV Gag protein, the rise of polymorphisms from independent origin during the last twenty years of
epidemic in our setting was related to an association with an HLA allele. The fact that these mutations accumulated in one
of either B or F subtypes have also dominated the other subtype shows how this selection might be causing a convergence
of viral subtypes to variants which are more likely to evade the immune response of the population where they circulate.
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Introduction
HIV-1 evasion of immune response occurs through selection of
mutations that impair recognition by immune effectors. Cytotoxic
T-Lymphocyte response is a key factor in HIV infection by
limiting viral replication, which is translated into a pronounced
reduction of the viral load at the acute phase of infection [1,2,3].
This strong selective force leads to the rise in variants harboring
CTL-escape mutations [4,5,6]. These mutations impair the affinity
of the epitope for the HLA molecule [7,8,9] or the interaction
between the T-cell receptor (TCR) and the peptide-HLA class I
complex [10], allowing the virus to replicate more efficiently. The
selection and spreading of CTL-escape mutations may impact the
efficacy of immune response at a population-level, whether it is
natural[11,12] or intended to be stimulated through vaccination
[13,14,15]. Regarding this issue, understanding the epidemiology
of CTL-escape mutations is of significant interest for immunogen
design and to assess how HIV might adapt to the immune
response of the human population.
The aim of this study was to seek for evidence of HLA-driven
evolution during the last two decades of the epidemic. Plasma
samples obtained from 252 newly diagnosed individuals between
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3429the years of 1987 and 2006, together with HLA typing, were used
to identify CTL-escape mutations and analyze their dynamics at a
population-level. Statistical analysis used in conjunction with
phylogenetic techniques allowed us to dissect the patterns of HLA-
mediated evolution of HIV-1 circulating strains.
Methods
Subjects and Samples
All the samples included in this study were obtained from HIV
newly diagnosed individuals, all of them naı ¨ve of antiretroviral
drug treatment. The 103 sequences used for identification of CTL-
escape mutations were obtained from samples collected at a
voluntary counseling and testing site in operation at the Ramos
Mejia Hospital in the city of Buenos Aires between March 2003
and April 2004. In these cases, PBMC samples were also available
on which HLA typing was performed. Confidential one-on-one
interviews were conducted onsite by health care workers. During
these encounters, the study was explained and subjects were
invited to participate. Only those subjects who were willing to
participate were provided with a written informed consent,
enrolled, and sampled.
The additional 149 sequences used for analysis of trends in time
were retrospectively obtained from plasma samples collected
between 1987 and 2006 at 5 different voluntary counseling and
testing sites in the city of Buenos Aires, all of them corresponding
also to antiretroviral drug naı ¨ve and newly diagnosed individuals.
In these cases only the virus was characterized and no linkage to
patient’s data was performed. All the experiments were approved
by the Research Ethics Committee of the School of Medicine,
University of Buenos Aires (OHRP ref num: IORG0004063).
Sequencing of viral RNA
Sequences were obtained by nested RT-PCR amplification of
RNA extracted from plasma samples using the QIAamp viral
extraction kit (QIAGEN GmbH, Hilden, Germany) and further
automatic sequencing using the ABI Prism 3100/Genetic
Analyzer (Applied Biosystems, CA). Sequence edition was
performed using the Sequencher 4.8 software (Gene Codes Co.,
Ann Arbor, MI). Amplified viral regions for this study included gag,
pol and vpu genes: HXB2 positions 682 to 2042, 2143 to 3798 and
5969 to 6595, respectively. Sequence alignment was performed by
using Clustal W (BioEdit 7.0.4.1 sequence alignment editor[16]),
and codon optimization was performed using GeneCutter (by
Brian Gaschen, http://www.hiv.lanl.gov/content/hivdb/GENE_
CUTTER/cutter.html).
For gag gene amplification, outer primers 1gagFW (59-CTAG-
CAGTGGCGCCCGAACAGG-39)a n d1 g a g R e v( 5 9-CAGTC-
TTTCATTTGGTGTCCTTC-39), and inner primers 2gagFW
(59-TCTCTCGACGCAGGACTCG-39)a n d2 g a g R e v( 5 9-
TTTCCACATTTCCAACAGCCC-39)w e r eu s e d .F o rpol gene
amplification, outer primers 5CP1 (59-GAAGGGCACACAGCCA-
GAAATTGCAGGG-39)a n dR T 3 . 1( 5 9-GCTCCTAC-
TATGGGTTCTTTCTCTAACTGG-39), and inner primers 1F
(59-CAGACCAGAGCCAACAGCCCC-39), A35 (59-ATTGGT-
TGCACTTTAAATTTTCCCATTAGCCCTATT-39), 6B (59-
CATTGTTTAACTTTTGGGCC-39), RT3208F (59-AACATCA-
GAAAGAACCTCCATT-39), NE1 (59-CGACCTGACAGT-
TACTGTATGTCTTCAATCACC-39) and RT3798 (59-
CAAACTCCCACTCAGGAATCCA-39) were used. For vpu gene
amplification, outer primers PolSeq2 (59-CGGGTTTATTACAGG-
GACAGC-39)a n dT U E - 3( 5 9-TCCTTCTGCTAGACTGC-
CATTTA-39), and inner primers ACC7 (59-CTATGGCAGGAA-
GAAGCGGAGA-39) and ZM140E (59-GGGGTCAACTTTAC-
ACATGGCTTT-39) were used. GenBank accession numbers:
FJ155074 to FJ155325.
HLA class I typing
HLA class I typing was performed on extracted genomic DNA
by PCR-SSOP technique according to standard procedures.
Statistical analysis for the identification of potential CTL-
escape mutations
We performed an analysis according to the method described
by Moore et al.[17]. First, we carried out a univariate analysis of
correlations between the presence or absence of HLA alleles and
the presence or absence of polymorphisms at each position of the
gag, pol or vpu region analyzed, considering those residues that are
different from the consensus sequence obtained from the same set
of data as polymorphisms.
We eliminated those pairs of HLA-positions from the analysis
where any of the four cells in the two-by-two table had an actual or
expected count lower than 4.5. Then we performed Fisher’s exact
test obtaining a p-value that we used as a filter, eliminating those
associations with a p-value lower than 0.1. We also estimated the
power of the analysis for every HLA-position pair analyzed and
eliminated that had a power lower than 30%.
We then performed a multivariate analysis by logistic regression
with backwards elimination considering HLA alleles as regressors.
We kept associations having a p-value lower than 0.05.
Then we performed a correction for multiple comparisons by
calculating the q-value of each association by the Benjamini-
Hochberg methodology. In the present study, potential CTL-
escape mutations were those polymorphisms that passed through
this analysis with a q-value lower than 0.2 (in our data set
equivalent to an adjusted p-value lower than 0.0140).
Correction for Multiple Comparisons
To control the inflated Type I error rate associated with
multiple significance tests, the false discovery rate procedure
developed by Benjamini and Hochberg was used to calculate
adjusted p-values. This linear step-up approach controls the
expected proportion of falsely rejected null hypotheses (i.e., the
false discovery rate is expected to be no greater than 20%) and has
some advantages (including more power) over Bonferroni-type
procedures that control the family-wise error rate.
Phylogenetic Comparative Analyses
Phylogenetic comparative analyses were performed through the
BayesTraits program by Mark Pagel and Andrew Meade available
at http://www.evolution.reading.ac.uk/ [18,19]. An evolutionary
model for the data was inferred using the Modeltest program[20]
and the model was implemented in PAUP4.0 (http://paup.csit.fsu.
edu/) to estimate branch lengths of the trees obtained as described
above. For the Monte Carlo analyses, 10E6 iterations were run
with a sampling frequency of 300 and a burn-in length of 50,000.
For each position, the RateDev parameter was set so as to ensure a
20–40% acceptation rate. Currently there are no phylogenetic
methods that take into account recombination, therefore only
sequences previously characterized as ‘‘pure’’ (non-recombinants)
could be analyzed.
Viral Subtype Characterization
Sequences were aligned with references from the Los Alamos
HIV Sequence Database (http://hiv-web.lanl.gov/content/hiv-
db/SUBTYPEREF/align.html) using Clustal W (BioEdit 7.0.4.1
sequence alignment editor[16]), and codon optimization was
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lanl.gov/content/hivdb/GENE_CUTTER/ cutter.html) and
hand aligning. After gap stripping, Neighbor-joining (NJ) trees
were constructed under the Kimura two-parameter model with
MEGA3.20. All sequences were individually analyzed for
similarity with consensus references by SimPlot analysis (Simplot
2.5 by Stuart Ray,21 http://sray.med.som.jhmi.edu/RaySoft/
SimPlot/). Sequences bearing similarities to two or more different
subtypes were further analyzed by Bootscanning (Simplot 2.5 by
Stuart Ray,21 http://sray.med.som.jhmi.edu/RaySoft/SimPlot/)
and by visual inspection of alignments in order to identify
recombination breakpoints.
Phylogenetic Analyses
Phylogenetic trees were obtained using the TNT software
(available at http://www.zmuc.dk/public/phylogeny/TNT). This
software implements new technologies for dealing with large
datasets [21]. We used a combination of Tree Fusing, Ratchet,
Tree Drift and Sectorial Search (T-R-Df-SS) applied successively
to the best trees obtained from 100 Random Addition Sequences
followed by Tree Bisection Reconnection (RAS+TBR). The T-R-
Df-SS was applied three times on each RAS+TBR. The best trees
from each round were saved for ‘‘feeding’’ the subsequent rounds
of T-R-Df-SS, i.e., they were fused to the trees obtained in each
RAS+TBR. This scheme was repeated 10 times over 15 hours and
the resulting trees were fused to verify that no further
improvements of length were possible, at least under this
experimental setting.
Statistical Analyses of Trends in Time
Statistical analysis was performed by the General Linear Model
Repeated Measures analysis. Samples were classified by sampling
year, OR (lower or higher than 1) and viral subtype (B or F). The
within-subjects factor was the sampling year with 3 levels: 1987–
1997, 1998–2002 and 2003–2006. The between-subjects factors
were as follows: (1) Positive associations (those with OR.1), (2)
Negative associations dominating a viral subtype (those with
OR,1 and the subtype where they have always been at a higher
prevalence) and (3) Negative associations not dominating a viral
subtype (those with OR,1 and the other subtype). The sample
size for each level was 18, 4 and 4 respectively (level 1: escape at
positions P28, P46, P55, P65, P81, P118, P242 and P375; level 2:
escape at positions P030, P084 and P125 in subtype B and P083 in
subtype F and level 3: escape at positions P030, P084 and P125 in
subtype F and P083 in subtype B). Assumption of equality of
covariance matrices were assessed by Box’s Test (F12; 285.5=1.489;
p=0.127), assumption of sphericity was assessed by Mauchly’s
Test (p=0.112), assumption of equality of error variances was
assessed by Levene’s Test (F2; 21=1.024; p=0.376 for T1/F2; 21
=0.117; p=0.890 for T2/F2; 21=0.002; p=0.998 for T3).
Interaction between fixed factors was significant (F4; 42=13.892;
p,0.001), therefore analysis for simple effects was performed by
one-way ANOVA for each between-subjects level. Results for each
group was F2; 45=1.543 p=0.225 for level 1, F2; 9=1.035
p=0.394 for level 2 and F2; 9=4,252 p=0.050 for level 3.
Results
The strongest CTL response in Gag protein is mediated
by HLA alleles B57 and A03
In order to compile evidence of HLA-mediated selection in the
viral variants circulating in our region, we sequenced the gag gene
in 103 samples obtained from newly diagnosed HIV-positive
individuals. After sequence alignment and editing, a total of 1210-
bp from the viral genome were translated into amino acids and,
together with the host HLA-A and HLA-B genes characterized in
the same group of patients, they were analyzed according to the
methodology previously described by Moore et al [17] in order to
identify potential CTL-escape mutations. Briefly, this analysis is
based on the fact that polymorphisms that reduce the affinity of a
peptide for the HLA-molecule are expected to be significantly
higher in frequencies in infected individuals harboring the selective
allele. Through this analysis, we found a total of 75 polymorphisms
significantly associated with different HLA alleles in our
population (p-value,0.05, logistic regression). Correcting for
multiple tests, 22 out of the 75 associations had a q-value lower
than 0.2 according to Benjamini and Hochberg method (Table 1,
Figure S1). These are the viral protein sites where immune
pressure is most likely to be acting. In fact, nine of them were
found inside known or predicted epitopes according to Los Alamos
Best-defined CTL/CD8+ Epitope Summary [22] and both the
NetMHC 3.0 (CBS Prediction Server, Center for Biological
Sequence Analysis, Technical University of Denmark [23]) and
Epipred softwares (Microsoft Research [24]), respectively.
Comparative biological data might not be statistically indepen-
dent due to a shared phylogenetic history and therefore violate one
of the basic assumptions of most standard statistical procedures.
This problem can be solved by incorporating phylogenetic
information into the analyses [25]. These phylogenetic corrections
help to identify false-positive results in analyses of association
between HLA alleles and viral polymorphisms due to linkage
relationships between individuals bearing those polymorphisms
[26].Therefore, we applied this approach to our study. We first
removed all the recombinant sequences from the analysis in order
to avoid confounding effects on phylogeny inference. Afterwards,
we applied a Bayesian Markov Chain Monte-Carlo method to the
22 associations to correct for phylogenetic correlations [19]. As
shown in Table 1, we found four associations to be strongly
supported after phylogenetic correction and six to be moderately
supported (see also Table S1). The majority (7/10) of the
associations supported by phylogenetic correction were at the
same time within well-defined or predicted epitopes. Among the
12 unsupported associations, two of them were also found inside
known or predicted epitopes. The remaining 10 associations were
considered likely to be false-positive.
Escapes at epitopes KYKLKHIVW and SLYNTVATL have
significantly increased in time during the last twenty
years of epidemic
Having identified those positions under immune pressure, we
aimed to analyze the dynamics of these escape mutations at a
population-level. In order to assess this issue, we first sequenced
the gag gene from an additional set of 149 plasma samples obtained
from newly diagnosed individuals from the years 1987 to 2006 (see
Table S2). Then, we classified sequences according to the viral
subtype and sample collection year and analyzed the frequency of
those polymorphisms identified as CTL-escape mutations at three
different intervals of time. Phylogenetic analysis showed that 93
(36.9%) out of the 252 samples belonged to subtype B, 55 (21.8%)
were subtype F, and 103 (40.9%) were BF recombinants, which is
consistent with the fact that in South America, subtype B variants
co-circulate with inter-subtype BF recombinants with similar
prevalence. One sample belonged to subtype C. Regardless of the
high prevalence of recombinant forms between subtypes B and F,
the majority of them share a common recombination pattern,
which allows us to classify them according to the structures of
recombination; among the 103 recombinants, 68 (66%) of them
shared the same recombination pattern with a short subtype B
HIV-1 Evolution
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confounding effects of recombination and to prevent the loss of
analyzable samples, we eliminated those sequences that did not
have the common structure and considered the remaining BF
recombinants as B for those mutations located at the 59-B segment
and F for those mutations located at the 39-F segment.
As shown in Figure 1 (upper panel), we found that polymor-
phisms identified as escape mutations have had a wide range of
behaviors. Mutations such as those identified at positions 30 and
83 have increased significantly in time (p,0.05, Chi-squared for
trend) in subtype B and subtype F, respectively, while other
mutations have remained either at a low prevalence as the
majority, or dominating one of either subtypes B or F.
Interestingly, mutations at positions 30 and 83 seem to have
reached a high prevalence in time until becoming the most
common residue for subtypes B and F, while they have always
been at a high prevalence in subtypes F and B, respectively. The
same was observed for escape at position 125, dominating subtype
F and increasing in subtype B, although not statistically significant
in our data set (p=0.211). In fact, these three escape mutations
were identified through negative associations (OR,1) as the
escape is currently the consensus state at those positions. Next, we
estimated site-specific synonymous (dS) and non-synonymous (dN)
substitution rate parameters using a maximum-likelihood method
[27,28]: We found that 194 out of the 399 analyzed sites were
subjected to a significant negative selection and 24 sites were under
significant positive selection (p-value,0.05). Among the last group
sites 76 (p=0.016), 84 (p=0.027), 125 (p=0.007) and 280
(p=0.002) were included.
CTL selective pressures shape the evolution at a
population-level of the majority of residues significantly
changing in time
Next, we hypothesized that if HLA-mediated selection is a force
strong enough to induce a shift in state at different viral protein
Table 1. Summary of the 22 potential CTL-escape mutations identified through statistical analysis.
Position States Adjusted Epitope Analysis
HLA Consensus Polimorphism HXB2 position OR p-value p-value Sequence Known/predicted
Correlations strongly supported as escape by phylogenetic correction
A03 K Q R P028 21.0 ,10
27 0.0006 RLRPGGKKKK Known
B57 T N P242 54.7 0.0002 0.0013 TSTLQEQIGWF Known
A11 A K M T V P118 10.5 0.0018 0.0019 KTQQAAADK NetMHC
A03 E D G P055 4.8 0.0123 0.0139 - -
Correlations moderately supported as escape by phylogenetic correction
B07 G S P357 13.8 0.0050 0.0051 GPGHKARVL Known
A24 R K P030 0.21 0.0076 0.0070 KYKLKHIVW Known
A11 G S P357 13.2 0.0070 0.0063 GVGGPGHKAR Known
A02 Q H P065 4.8 0.0031 0.0025 ILGQLQPSL Epipred/NetMHC
B40 T A P081 5.8 0.0084 0.0076 - -
A24 V L I P046 3.4 0.0090 0.0082 - -
Correlations inside known or predicted epitopes but not supported by phylogenetic correction
A02 A V P083 0.13 0.0043 0.0038 SLYNTVATL Known
A01 GAP/N S P125 NPC 0.0105 0.0114 NSSQVSQNY Epipred/NetMHC
Correlations neither inside known or predicted epitopes, nor supported as escape by phylogenetic correction (most likely false positives)
B49 K E Q A D P012 0.00 0.0116 0.0127 - -
B40 Q K R N P090 0.00 0.0104 0.0102 - -
A02 A P S T P146 0.27 0.0099 0.0095 - -
A01 L I V M P215 0.00 0.0105 0.0108 - -
A31 T S P342 0.12 0.0063 0.0057 - -
A31 N S T G P372 NPC 0.0099 0.0089 - -
B08 T V A P303 4.0 0.0047 0.0044 - -
B49 E D P312 15.6 0.0119 0.0133 - -
A01 P T S Q I P339 4.9 0.0042 0.0032 - -
A24 T S P342 5.9 0.0110 0.0121 - -
Detailed are the positions of the mutations in HXB2 Gag protein (http://www.hiv.lanl.gov/content/sequence/ LOCATE/locate.html, see Figure S1), the HLA allele
associated, the most frequent aminoacidic residue found at each position (consensus) and the polymorphisms found in those positions. All of the associations shown in
the table have a q-value lower than 0.2 (in our data set equivalent to an adjusted p-value lower than 0.0140). Mutations are classified accordingly to whether they were
strongly, moderately or not supported by phylogenetic correction and to whether they were or not located within known or predicted epitopes. In black-cursive are
highlighted positions where escape was identified and enlarged are anchor residues for binding with the HLA molecule. In column 9 is detailed whether the mutations
was located within a known epitope (‘‘Known’’) according to Los Alamos Best-defined CTL/CD8+ Epitope Summary or predicted epitope according to the NetMHC 3.0
(‘‘NetMHC’’, CBS Prediction Server, Center for Biological Sequence Analysis, Technical University of Denmark) and/or Epipred softwares (‘‘Epipred’’, Microsoft Research).
NPC: not possible to calculate.
doi:10.1371/journal.pone.0003429.t001
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impair viral fitness tend to reduce the strength of the association;
transmission without reversion would increase the prevalence of
escape mutations in individuals not harboring the selective HLA-
allele leading to a loss of statistical power [29]. Therefore, they
would not be identified by statistical-based approaches. In order to
test whether changes that have accumulated in other positions
might have been driven by immune selection, we screened the
analyzed viral region looking for other polymorphisms significantly
changing in time. First, we classified samples according to sampling
year and viral subtype, and then performed a Chi-squared analysis
for trends. We found that 12 out of the total 399 positions have
significantly changed over time in at least one of either the B or F
subtypes (p-value,0.05, Table 2). Nine of them were within known
CTL-epitopes and the remaining four within predicted epitopes.
According to prediction software [23], nine of them are likely to
impair affinity for the HLA molecule. Particularly, in the three
positions where our data set had enough statistical power, we found
evidence of associations with HLA alleles: two of them were already
identified as potential CTL-escape mutations (Mutations in
positions 30 and 83, Table 1) and mutation at position 84 had an
OR of 0.34 and a p-value of 0.0716 for association with HLA-A02.
Again, the higher changes in time were observed for those
mutations identified through negative associations (Figure 1, lower
panel and Table S3).
CTL-escape mutations follow three different behaviors in
time
By classifying mutations by OR it is possible to observe the
different behavior in time of those mutations reaching a negative
association compared with those identified through positive associ-
ations. As shown in Figure 2, the latter have always remained at a low
prevalence (,30%), not changing in time (F2, 45=1.543; p=0.225),
while the former have significantly increased in time (F2,9=4,252;
p=0.050) in the subtype where they are not dominant. Interestingly,
mutations found to significantly accumulate in time are associated
with highly frequent HLA alleles. In fact, alleles A02 (associated with
escape at positions 83 and 84), A01 (associated with escape at position
125) and A24 (associated with escape at position 30) are among the
five most prevalent HLA alleles in our population according to
independent data (http://www.allelefrequencies.net, Figure S2).
Discussion
This study shows the dynamics of CTL-escape strains of HIV
present in newly diagnosed individuals during the last twenty years of
Figure 1. Trends in time of polymorphisms identified as potential CTL-escape mutations. Trend lines for the 3-point in time prevalence
estimated are shown (prevalence estimated at each time available in table S3). Mutations were classified according to viral subtype (Subtype F in left
panel, subtype B in right panel), according to whether they were identified through statistical analysis (upper panel) or trend analysis (lower panel),
and according to whether they were identified through negative (black) or positive (blue) ORs. Mutations at positions P30 and P83 are repeated on
upper and lower panels as they were significantly associated to an HLA allele (q-value,0.2) and also shown a significant trend in time (Chi-squared
for trend ,0.05). Except for mutations on positions P30 on subtype F and P215 on subtype B, trends are toward an increase or a stable prevalence in
time. Particularly, those that are at present the most common state (identified through negative OR, black lines) show the higher increase in time.
doi:10.1371/journal.pone.0003429.g001
HIV-1 Evolution
PLoS ONE | www.plosone.org 5 October 2008 | Volume 3 | Issue 10 | e3429the epidemic. Our findings support the primary role for population-
level CTL immune response in shaping the evolution of circulating
HIV strains. It has been previously suggested [6,17,29] that negative
OR (OR,1) might be the result of the accumulation of escape
mutations. Particularly, Leslie et al [6] have previously explored this
idea analyzing two common CTL-escape mutations. However,
Battacharya et al [26] reevaluated these data and found that these
highly prevalent escape mutations were more likely to have been in
the founder virus of the analyzed viral subtype, supporting this
conclusion by showing that the frequency of escape and non-escape
forms remained constant over time. In contrast, in our study, we
found four highlyprevalent escape mutations and evidence tosupport
the hypothesis that they have accumulated in time until becoming the
most common state. Although only one of the four remained
significantly associated with the HLA allele (Position 30 with A24)
after phylogeneticcorrection, mutation T84V in the eighth residue of
A02-restricted epitope SLYNTVATL was previously shown to
diminish the specific CTL response [7]; and mutations V83A on
the seventh residue of epitope variant SLYNTVVTL and S125N in
the second residue of A01-restricted epitope NSSQVSQNY are
predicted to diminish the affinity for the HLA molecule (IC50
104 nM to 162 nM and 61 nM to 15,205 nM, respectively [23]).
The four mutations were found not to have dominated HIV variants
sequenced from the early epidemic in one of either B or F subtypes,
three of them showing a significant trend in time (p,0.05, Chi-
squared for trend, Table 2) toward an increase in their prevalence. In
fact, screening the sequenced region of gag for other positions
significantly changing in time, we found seven out of the additional
ten mutations identified through this methodology to be located
within known epitopes and the remaining three within predicted
epitopes. Interestingly, four of them were specifically located in
anchor residues for HLA binding and three of them showed a
significant association with an HLA allele. As shown in Table 2,
except for those three associations, limitations in our data set preclude
the analysis to detect further associations due to the lack of sufficient
statistical power. Therefore, it is possible that those associations
confirminganHLA-mediatedselectiondoexistalthoughwewerenot
able to detect them due to the reasons stated above. Also, the lower
number of sites significantly changing in time found in subtype F
compared with subtype B might be related with the lower samplesize
for the first group and the consequent lower statistical power to detect
significant trends.
Considering that at a host-level it was shown that the majority of
fixed amino acids substitutions are associated with CTL-response
[10,30], our results seem to show a similar phenomenon at a
population-level, suggesting that the majority of gradual increases in
mutations across Gag protein might be driven by HLA-mediated
immune responses.
Table 2. Summary of the 12 polymorphisms found to have significantly changed in time during the last twenty years.
Residue
position p-value for trend Position states Sequence of known eptiopes In our study
State that
increases in
time
Subtype B Subtype F Consensus Polimorphims OR Power p-value
Inside known epitopes
P030 0.038 0.106 R K KW9-A24: KYKLKHIVW 0.23 0.83 0.0055 R
GK9-B08: GGKKKYKLK NC 0.42
P076 0.029 0.030 R K RY11-A30: RSLYNTVAVLY 1.70 0.08 K
EV9-B08: ELRSLYNTV 1.25 0.05
P083 0.904 0.031 A V SL9-A02: SLYNTVATL 0.10 0.94 0.0008 A
RY11-A30: RSLYNTVATLYN C ,0.01
P084 0.012 0.730 SL9-A02: SLYNTVATL 0.34 0.77 0.0716 V
VT RY11-A30: RSLYNTVATLY 1.79 0.13
TI9-A11: TLYCVHQRI 2.83 0.30
P095 0.088 0.040 K R IL10-B40: IEIKDTKEAL 0.82 0.15 K
P215 0.031 0.930 L V EL9-B40: EEAAEWDRL 0.42 0.15 L
P218 0.047 0.770 V A AV9-B40: AEWDRLHPV 2.84 0.29 A
HA9-B07: HPVHAGPIA NPC 0.03
P223 0.123 0.009 I V HA9-B07: HPVHAGPIA 1.55 0.13 V
P280 0.601 0.020 V T RI8-B52: RMYSPTSI (1) 2.61 0.11 T
VI9-CW18: VRMYSPVSI (1) NPC NPC
Inside predicted epitopes
P090 0.614 0.028 Q K R AK9-A11: AVLYCVHQK (2)
CK9-A03: CVHKKIEVK
P054 0.555 0.009 S A P T EI9-B68: ETAEGCRQI (1) (2)
P138 0.628 0.040 L A F H I M P V NL8-A24: NYPIVQNL (2)
Detailed are the p-values obtained by Chi-squared test for trend. Note that except for position P76, the other positions have significantly changed only in one of either
the B or F subtype. Aminoacidic sequences of known epitopes surrounding these mutations are shown, and highlighted in black-cursive the residue that changed.
Enlarged are the anchor residues for binding to the HLA molecule. Statistical results for the pair position-HLAallele in our study are detailed. Note that we only have
enough statistical power to detect association at positions P30, P83 and P84. (1) In these cases no information was available of anchor residues. (2) In these cases was
observed a significant increase in time of all the residues alternatives to the consensus residue as a group. NPC: not possible to calculate.
doi:10.1371/journal.pone.0003429.t002
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antiretroviral therapy was developed and became progressively
more efficient, we considered the possibility that the increased
prevalence we observed be driven by antiretroviral therapy
mediated selection. Among Gag protein, sites under selective
pressure mediated by ARV drugs would be those where Protease-
mediated cleavage occurs. We found that two of the mutations
analyzed (those at positions 125 and 357) were located within
epitopes that overlap the two cleavage sites located within the viral
region analyzed in our study: VSQNY/PIVQN and KARVL/
AEAMS. However, none of the mutations analyzed in our study are
located within these sites and therefore their selection is likely to be
independent of those selective forces acting over these cleavage sites.
It is important to mention that we are analyzing samples at the
chronic stage of infection. In fact, considering the delay from
infection to diagnosis that is common in our country it is likely that
the majority of samples were obtained from individuals with
advanced stages of infection. It could be possible that changes in
escape mutations are influenced by disease progression; however it
is expected that the majority of CTL-escape mutations to be
selected at early stages of infection [31] and to persist after several
years of infection [10] making samples collected even at advanced
stages of infection suitable for prevalence analyses of CTL-escape
mutations.
By classifying samples according to OR for associations with the
HLA allele, it is possible to dissect the different dynamics in time
for CTL-escape mutations identified through negative or positive
associations. Those identified through positive associations seem to
have remained constant over time at a low frequency, while those
identified through negative associations (now the consensus state)
have increased significantly in time. Other mutations found to
have significantly changed in time and located in HLA-binding
anchor residues, such as mutations at position 76 (third residue of
B08-restricted epitope ELRSLYNTV[32,33]) in our study, might
have lost their associations with the HLA-allele as a consequence
of the spreading of escape variants to individuals not harboring the
selective allele, even more rapidly if the selective allele is at a
relatively low prevalence in the population (as is HLA-B08 for
escape at position 76). The reason underlying the trend toward
accumulation or not might be related with the fitness cost of the
mutations selected. Among mutations identified through positive
association, T242N in B57-restricted epitope TW10 is the best
characterized and was shown to dramatically diminish the
replication capacity of HIV [6,34]. Also within this group is the
mutation K28QR in A03-restricted epitope RK9 that was shown
to be selected in the presence of A03 allele and to revert in the
absence of HLA-mediated selective pressure [8,35]. On the other
hand, three out of the four mutations identified through negative
associations are located in positions subjected to positive selection,
therefore, able to adaptively evolve. In this sense, our analysis of
dS/dN rate might shed some light on this issue as it is expected for
sites that have significant relevance for viral fitness to be
functionally constrained (undergoing a negative selection) while
those sites that are less restricted to change may be able to evolve
adaptively (undergoing positive selection). We found that while the
majority of positions analyzed are subjected to negative selection
(i.e. selection toward conservation of HIV genome identity), two
out of the four positions (84 and 125) where escape was identified
through negative ORs are subjected to positive selection. These
results suggest that the accumulation of escape is possible in those
positions where HIV is not highly restricted to change, while in
positions undergoing negative selection, escape is more likely to
revert. Also, there is evidence that mutation at position 30 (also
identified through negative association) has no effect on HIV-1
replication in human T-cell lines (C.S. Adamson and E. O. Freed,
personal communication).
Moreover, accumulation of these mutations in one viral subtype
while dominating the other viral subtype might lead to an
evolutionary convergence mediated by immune selection as shown
in Figure 3 and suggests that viral subtype, at least B and F in our
population, might be a relevant feature regarding adaptation to
immune response as the presence of the escape in the early
ancestors would give the subtype harboring it an advantage at an
epitope level against immune response mediated by the corre-
sponding HLA allele. This advantage might be extended to other
viral proteins. When we repeated the statistical analysis for the
identification of escape mutations over pol and vpu genes, we found
that 5 out of 19 potential CTL-escape mutations were character-
istic of either the B or F subtypes, again showing a potential
subtype-dependent advantage for immune evasion (see Table S4).
The overall idea that viruses are adapting to more efficiently
evade the human immune system across time of HIV/AIDS
worldwide epidemic implies that they are increasingly more fit
over time. In contrast, Arien et al [36] have shown that HIV
viruses are increasingly less fit over time in the human host. Our
results are not necessarily inconsistent with reports from Arien and
colleagues as a reduced replicative fitness in head-to-head
competition experiments are expected consequences for a virus
that is progressively less virulent for the host; and the increased
efficiency in evading the immune response at a population-level
described in our study would lead to earlier rises in viral load, what
Figure 2. Mean frequency of escape mutations across time.
Percentage of sequences harboring the escape mutations are
represented on the vertical axis. As there is no previous data available
to know what mutations might dominate B or F subtype, classification
of mutations had to be performed a-posteriori: Those found to
dominate a viral subtype (green line) and the remaining according to
whether they were identified through negative (blue line) or positive
(red line) ORs. Groups compositions were as follow: red group=P028,
P046, P055, P065, P081, P118, P242 and P375 in both subtype B and F;
blue group=P030, P084 and P125 in subtype B and P083 in subtype F;
green group=P030, P084 and P125 in subtype F and P083 in subtype B.
Statistical analysis performed by GLM Repeated Measures showed that
these three groups have had significantly different behaviors in time:
escape mutations identified through positive associations have always
remained in a low prevalence while those identified through negative
associations (as they are now the most common state) have always
dominated one of either B or F subtype, or been previously in a low
prevalence and increased significantly in time until becoming the most
prevalent state in the subtype they do not dominate. These trends
suggest a convergence of viral subtypes mediated by HLA selection.
doi:10.1371/journal.pone.0003429.g002
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event of exposure. Both, a lower virulence and an increased
transmissibility are characteristics expected for viruses more fitted
to the population of hosts where they circulate [37]. It is important
to note that higher levels of viral load may lead to higher rates of
CD4-positive T-cells decline which is associated with a more
virulent virus; however, it has been recently shown that a decline
in CD4 count and not an increase of viral load is a better predictor
of disease progression [38].
In summary, we found evidence of HLA-mediated selection in
HIV variants circulating in our population and the escape
mutations selected to follow three different behaviors in time:
remain at a low prevalence, increase significantly in time or
constantly dominate an entire viral subtype. Remarkably, only one
of them (mutations at position 30 in subtype F) was found to have a
decreasing trend in time, although it was not significant (p=0.106).
In this sense our results shed some light into the rationality for
vaccine design as the fact that some mutations have the potential
to accumulate in time means that vaccines targeting epitopes
containing them will eventually reduce their effectiveness.
Therefore, to identify CTL escape mutations that are restricted
to spread like those classified as ‘‘positive associations’’ in this
study, should be a key factor for the development of future
vaccines [39]. We also found that HLA-mediated selection, as it is
known occurs at host-level, may also account for the majority of
temporal trends of residues significantly rising in time at a
population-level. Finally, the presence of the escape state as part of
the natural genome of a viral subtype suggests a subtype-related
evolutionary advantage and shows the force of HLA-driven
evolution to induce a convergence of viral subtypes to HIV
variants better able to evade the immune response of the
population where they circulate.
Supporting Information
Figure S1 Consensus sequence obtained for the HLA/poli-
morphism analysis. Highlighted are positions where potential
CTL-escape mutationes are located, underlined those identified
through statistical analyisis.
Found at: doi:10.1371/journal.pone.0003429.s001 (0.97 MB
PDF)
Figure S2 Phenotype frequency of HLA allele. Observed
frequencies in general population (gray bars, obtained from
www.allelefrequencies.net, popstudy:Argentina-Buenos Aires) and
in our study (black bars) are shown. In general, frequencies
observed in our HIV-1 infected population resemble the
frequencies in the general population although some alleles are
overrepresented (A24, A68, B39, B07, B40, A31 and B62).
Found at: doi:10.1371/journal.pone.0003429.s002 (0.80 MB
PDF)
Table S1 Results obtained from the phylogenetic correction
analysis. Details of the results obtained from the phylogenetic
correction performed over the 22 positions where polymorphisms
were significantly associated with an HLA allele (q-value,0.2).
Five trials were performed per position. When the best model
fitted to data is the independent model, this is shown on the sixth
columm.
Figure 3. Trends in time of escape mutations identified through negative ORs in both B and F viral subtypes. The four mutations
identified are currently in the majority of circulating HIV strains, regardless of viral subtype. However, analysis of their prevalence back in time showed
that in the early years of epidemic they dominated only one of either the B or F subtype while they were in a low prevalence in the other subtype.
This means that they have accumulated in time and driven a convergence of viral subtypes toward variants more able to evade the immune response
of the human hosts.
doi:10.1371/journal.pone.0003429.g003
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PDF)
Table S2 Details of the sequences analyzed in our study
according to sampling year and viral subtype. In our study,
samples were characterized as subtype B (B), F (F), C (C) or
recombinants between the subtypes B and F. In this last group
samples were further classified accordingly to whether they shared
the same structure of recombination with one recombination spot
at nucleotide 200 (989 in HXB2) in our alignment (BF200) or
other recombinant structures (BF).
Found at: doi:10.1371/journal.pone.0003429.s004 (1.27 MB
PDF)
Table S3 Frequencies of the 18 potential CTL-escape muta-
tions. Detail of the frequencies of the 11 polimorphisms identified
as potential CTL-escape mutations through statistical analysis
(mutation at position 357 was associated with two different HLA
alleles) and the 7 additional identified through trend analysis,
according to viral subtype.
Found at: doi:10.1371/journal.pone.0003429.s005 (1.05 MB
PDF)
Table S4 Results from the statistical analysis for identification of
CTL-escape mutations performed over genes pol and vpu.
Detailed are the p-values and ORs of the 19 sites across pol and
vpu genes where evidence of CTL-escape mutations were found.
Correction for multiple comparisons where performed and only
associations with a q-value lower than 0.2 are shown. For those
positions located within known or predicted epitopes, the
aminoacidic sequence is detailed. For those significantly associated
with viral subtype, p-values for association and prevalence on both
B and F subtypes are provided.
Found at: doi:10.1371/journal.pone.0003429.s006 (1.09 MB
PDF)
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